Luiza Mihaela Ghila

Position

Researcher

Affiliation

Research

My research aims at studying the molecular switches acting as regenerative or cell-plasticity breaks by actively maintaining the cell fate, thereby ensuring the strict regulation of cell identity and/or numbers.

Currently, we are focusing on metabolic and immune players, which we recently identified to be involved in the emergence of the immediate neoplastic transformation signature in a model of bladder cancer. We intend to resolve the causal relationship and contribution to mechanisms regulating cell fate and tumour development by abolishing or augmenting their impact, with the final goal of aborting early neoplastic transformation.

Previously, by using genetic cell fate-tracing techniques, I studied a spontaneous age-dependent regeneration process in the mammalian pancreas, based on a cell-fate conversion. Although a natural attempt of mammalian regeneration, this regenerative mechanism was extremely inefficient, with only 2% of the cells converting at any given time point (Thorel et al., Nature, 2010; Chera et al. Nature, 2014). We investigated the cellular and molecular mechanisms behind this restricted cell identity change and revealed that Insulin and Hedgehog signalling pathways act as natural cell-plasticity breaks by actively maintaining cell-identity (Cigliola*, Ghila*, Thorel* et al., Nature Cell Biology, 2018; *equal contribution). These results are neither organ-specific nor isolated, with an incremental body of literature reporting cell-plasticity breaks in many mammalian tissue and organs. Several recent studies pointed towards a short list of signalling pathways involved, reviewed by us in Cigliola, Ghila et al., 2020, Stem Cells. 

I am currently investigating the molecular mechanisms acting during cell reprogramming and differentiation using mouse models and hiPS-derived human cell models.  

Teaching
Publications
Lecture
Poster
Academic article
Academic lecture
Editorial
Abstract
Popular scientific article
Academic literature review

See a complete overview of publications in Cristin.

Projects

2021-2024 Mapping predictive cancer signatures in vivo (funded by Norwegian Cancer Society, PI) 

2020-2023 Supportive therapy for diabetes by increasing the stress endurance and regenerative capacity of beta-cells (funded by EEA and Norway Grants funding scheme, RoNo2019, work package leader)

2019-2020 Differentiating insulin-producing cells from induced pluripotent stem cells derived from diabetes patients (funded by Diabetesforbundet, PI)

2016-2019 Characterization of regulatory mechanisms in differentiating MODY-iPS-derived pancreatic cells (postdoctoral project funded by UiB, PI